KARUSTHERAPEUTICS.COM

Developing best-in-class medicines to treat cancer - Karus Therapeutics

KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy. We have applied our insights into the structure and biological function of individual PI3K and HDAC enzymes to. KA2237 – Phase I. KA2237 is a potent, dual-selective inhibitor of the p110β an...

http://www.karustherapeutics.com/

OVERVIEW OF karustherapeutics.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR KARUSTHERAPEUTICS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 15 reviews

5 star

3

4 star

6

3 star

4

2 star

0

1 star

2

Hey there! Start your review of karustherapeutics.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.8 seconds

FAVICON PREVIEW

16x16

CONTACTS AT KARUSTHERAPEUTICS.COM

Karus Therapeutics Ltd

2 Ven●●●●● Road

Sout●●●●pton , Hampshire, SO16 7NP

UK

4402●●●●1360

j.●●●@karustherapeutics.com

View this contact

Karus Therapeutics Ltd

Karus Therapeutics Ltd

2 Ven●●●●● Road

Sout●●●●pton , Hampshire, SO16 7NP

UK

4402●●●●1360

j.●●●●@karustherapeutics.com

View this contact

Karus Therapeutics Ltd

Karus Therapeutics Ltd

2 Ven●●●●● Road

Sout●●●●pton , Hampshire, SO16 7NP

UK

4402●●●●1360

j.●●●●@karustherapeutics.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2005 May 24
UPDATED: 2014 March 25
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

20

YEARS
5

MONTHS
0

DAYS

NAME SERVERS

1: ns27.worldnic.com
2: ns28.worldnic.com

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

15

SSL

EXTERNAL LINKS

6

SITE IP

134.0.20.66

LOAD TIME

0.797 sec

SCORE

6.2

PAGE TITLE

Developing best-in-class medicines to treat cancer - Karus Therapeutics | karustherapeutics.com Reviews

<META> DESCRIPTION

KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy. We have applied our insights into the structure and biological function of individual PI3K and HDAC enzymes to. KA2237 – Phase I. KA2237 is a potent, dual-selective inhibitor of the p110β an...

<META> KEYWORDS

1 about us

2 leadership

3 board of directors

4 scientific advisory board

5 clinical advisory board

6 investors

7 pipeline

8 news and events

9 press releases

10 events

CONTENT

Page content here

KEYWORDS ON PAGE

about us,leadership,board of directors,scientific advisory board,clinical advisory board,investors,pipeline,news and events,press releases,events,in the news,publications,careers,raquo;,innovative science,de novo,clinical pipeline,genesis building

SERVER

Apache

POWERED BY

PHP/5.3.29

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Developing best-in-class medicines to treat cancer - Karus Therapeutics | karustherapeutics.com Reviews

https://karustherapeutics.com

KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy. We have applied our insights into the structure and biological function of individual PI3K and HDAC enzymes to. KA2237 – Phase I. KA2237 is a potent, dual-selective inhibitor of the p110β an...

INTERNAL PAGES

karustherapeutics.com

1

Karus Therapeutics presenting at AACR Annual Meeting 2015 | Blog - Karus Therapeutics

http://www.karustherapeutics.com/blog/2015/03/karus-therapeutics-presenting-at-aacr-annual-meeting-2015

Dual Inhibitors of PI3K-p110β and p110δ. Dual Inhibitors of PI3K-p110β and p110δ. Karus Therapeutics is a. Focused on unlocking the human. Immune system to treat cancer and. Karus Therapeutics is a. Focused on unlocking the human. Immune system to treat cancer and. Karus Therapeutics presenting at AACR Annual Meeting 2015. The presentations will take place from 8am to 12pm on Tuesday 21 April 2015 in Section 34. Simon Kerry, Karus Therapeutics’ CEO will also be attending the conference. VAT No 871 4126 33.

2

Karus Therapeutics presenting at Sachs Immuno-oncology: BD&L and Investment Forum | Blog - Karus Therapeutics

http://www.karustherapeutics.com/blog/2015/04/karus-therapeutics-presenting-at-sachs-immuno-oncology-bdl-and-investment-forum

Dual Inhibitors of PI3K-p110β and p110δ. Dual Inhibitors of PI3K-p110β and p110δ. Karus Therapeutics is a. Focused on unlocking the human. Immune system to treat cancer and. Karus Therapeutics is a. Focused on unlocking the human. Immune system to treat cancer and. Karus Therapeutics presenting at Sachs Immuno-oncology: BD&L and Investment Forum. Stephen Shuttleworth, Karus’s CSO, will present and CEO Simon Kerry will also be attending the conference. Tel 44 (0)1235 829140. Fax 44 (0)1235 420517.

3

Company - Karus Therapeutics

http://www.karustherapeutics.com/company

Dual Inhibitors of PI3K-p110β and p110δ. Dual Inhibitors of PI3K-p110β and p110δ. Fighting cancer by combining the effectiveness of targeted therapy and immunotherapy in innovative, oral,. Fighting cancer by combining the effectiveness of targeted therapy and immunotherapy in innovative, oral,. We operate an outsourced business model: retaining drug design, experimental chemistry and in vitro biology research in-house, whilst outsourcing a significant proportion of our R&D activities to a network of inte...

4

Blog | Publications - Karus Therapeutics

http://www.karustherapeutics.com/blog/category/publications

Dual Inhibitors of PI3K-p110β and p110δ. Dual Inhibitors of PI3K-p110β and p110δ. Karus Therapeutics is a. Focused on unlocking the human. Immune system to treat cancer and. Karus Therapeutics is a. Focused on unlocking the human. Immune system to treat cancer and. Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors. Shuttleworth SJ, Silva FA, Cecil AR, Tomassi CD, Hill TJ, Raynaud FI, Clarke PA, Workman P.

5

Developing best-in-class medicines to treat cancer - Karus Therapeutics

http://www.karustherapeutics.com/home

Dual Inhibitors of PI3K-p110β and p110δ. Dual Inhibitors of PI3K-p110β and p110δ. With oral small-molecule immunotherapies. Karus is a leader in the design and development of innovative small-molecule drugs that combine targeted therapy and immunotherapy activity for the effective treatment of a diverse range of solid and hematological cancers. Our highly-experienced management team has a track-record of creating, developing and partnering therapeutic programs in Europe and North America.

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

howmarshall.wordpress.com

Howard | Howard's Blog

https://howmarshall.wordpress.com/author/howmarshall

SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London. June 11, 2010. I attended the Society of Chemical Industry. 8216;s one day conference on the bang-up-to-date topic of Drug Discovery Outsourcing. The organisers had arranged a great programme of speakers from big pharma to virtual R&D companies, service providers and CROs. Dr Alan Moodie, GSK. 8211; Drug Discovery outsourcing – a strategic choice. Dr Luigi La Vecchia, Novartis. Dr Andy Morley, AstraZeneca. Dr Step...

howmarshall.wordpress.com

SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London | Howard's Blog

https://howmarshall.wordpress.com/2010/06/11/sci-ddo-2010

SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London. SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London. June 11, 2010. I attended the Society of Chemical Industry. 8216;s one day conference on the bang-up-to-date topic of Drug Discovery Outsourcing. The organisers had arranged a great programme of speakers from big pharma to virtual R&D companies, service providers and CROs. Dr Alan Moodie, GSK. Dr Luigi La Vecchia, Novartis.

novo.dk

Portfolio - selected companies | Novo A/S

http://www.novo.dk/ventures/active-portfolio

We use cookies on this website. By using the website you accept our use of cookies. Portfolio - selected companies. Tel 45 3527 6500. Fax 45 3527 6510. Check the map to see where our portfolio companies are located and read about each one in the company profiles. Acacia Pharma is focused on the development of compounds for the prevention and treatment of. Harston Mill, Harston, Cambridge, CB22 7GG, UK. Allakos develops monoclonal antibody-based therapies to target eosinophils and mast cells. EPFL Innovat...

angels5k.org.uk

Portfolio of Companies Angels 5K Have Invested In

http://angels5k.org.uk/portfolio

A Personal View Of Angels 5K. Criteria For Investing In Your Business. Apply Here For investment. Tips For Investment Applicants. Becoming An Angel Investor. Becoming An Angel Investor. Application Forms For Investors. A Selection of Startups and Growing Companies who have been Backed by Angels 5K Investors. Anaxsys is a medical device company that develops and markets innovative respiratory devices that meet clinical needs. Michelson Diagnostics have developed a world-leading, patented, medical imaging ...

wyvernfund.com

Wyvernfund.com - Portfolio

http://www.wyvernfund.com/portfolio.html

The Wyvern Seed Fund has a mixed portfolio of investments across the two Universities. In addition to investments into new spin-out companies the Fund has been used to support the development and commercialisation of academic research and Intellectual Property, for example by establishing License Agreements or other collaborative ways of returning value from the science/technology. Apitope Technology is a biopharmaceutical company developing treatments for allergy and autoimmune diseases. Perpetuum has d...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

6

OTHER SITES

karussellvermietung.ch

Stromlose Karusselle - Karussellvermietung stromlose Karusselle Vermietung Mohrenkopfschleuder Schleudervelo Schweiz Quartierfest Geburtstagsfest

Vermietung von drei Karussellen in rot, blau oder orange. Unsere drei Karusselle sind einzigartig und seit über 40 Jahren beliebt. Entweder rot/weiss oder orange/weiss mit Feuerwehrauto, oder blau/weiss mit einem Tram. Die Kinder sind von allen dreien begeistert und das Karussell steht nicht mehr still. Einfach, unkompliziert, ökologisch, sympathisch. Die Mohrenkopfschleuder kann jedes Geburtstagsfest zum Gaudi machen. Sie ist schnell aufgestellt und einfach in der Handhabung.

karussellvermietung.info

STRATO

karussiablog.blogspot.com

karussiablog

Tema Sederhana. Diberdayakan oleh Blogger.

karussohn.com

Karusso wedding & life photography by Odette de Aguilera

karustad.no

Default Web Site Page

This domain is parked at AttendIT.

karustherapeutics.com

Developing best-in-class medicines to treat cancer - Karus Therapeutics

KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). KA2507 (highly-selective inhibitor of HDAC6). KA2237 (dual-selective inhibitor of PI3K-p110β and p110δ). A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy. We have applied our insights into the structure and biological function of individual PI3K and HDAC enzymes to. KA2237 – Phase I. KA2237 is a potent, dual-selective inhibitor of the p110β an...

karusticus.deviantart.com

Karusticus - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Artisan Crafts / Student. Deviant for 2 Years. This deviant's full pageview. Last Visit: 1 day ago. By moving, adding and personalizing widgets.

karustis.com

Welcome to Karustis.com

The Family Way with Dr. Jim" is now on DailyLocal.com. In the Life/Kids section. Http:/ www.dailylocal.com/life/kids/. Archives: The Family Way with Dr. Jim - previous columns. Guidance and Help for Life's Challenges, and for Creating Greater Happiness. experienced, caring, whole-person centered practical assistance. Caring for the needs. Of all individuals and families.

karustler.com

STRATO

karustones.com

Karustones

Passez à la navigation. Site en cours de conception. Vous voyez une version text de ce site. Pour voir la vrai version complète, merci d'installer Adobe Flash Player et assurez-vous que JavaScript est activé sur votre navigateur. Vérifier la conditions requises.

karustrucklines.com

Karus Truck Lines Trucking Company-Regional Cargo Transportation Service Provider

Bull; Contact Us. Bull; Site Map. Karus Truck Lines Regional Cargo Transportation Service. When choosing a trucking company to handle your important cargo needs, it is vital that you choose a company that is focused on the particular areas that represent your customers. Our west coast freight focus is just that, we provide superior services and communication to meet your freight shipping needs. Karus Truck Lines is a Pacific Northwest Trucking Company that specializes in regional freight service. The mos...